The CIO Shift: Lessons from SIM Boston’s Roundtable

On November 4th, I had the opportunity to speak at SIM Boston’s Life Sciences Roundtable, hosted at Dyne Therapeutics. The session focused on “The Evolving Role of the Life Sciences CIO,” and brought together about 35 to 40 biotech and pharma technology leaders, CIOs, VPs, and IT strategists, all navigating a space where the only real constant is change.

This wasn’t a typical tech panel with slides and scripts. It was a roundtable. A chance to share what’s actually happening, the friction, the progress, the big questions we’re all still figuring out. And as the conversations unfolded, one thing became very clear: the role of the life sciences CIO is evolving, and it’s doing so fast.

From “Keep the Lights On” to “Drive the Business Forward”

In life sciences, IT has always carried a heavy operational load, and for good reason. Compliance, security, validation, documentation… these aren’t optional. But that baseline is no longer the finish line. It’s the floor.

During our discussions, it was clear that expectations from boards and executive teams are shifting. Instead of asking, “Are our systems stable?” leadership is starting to ask, “How is technology helping us move faster?” and “What’s our strategy for AI, automation, or data integration?”

This change isn’t just about tech, it’s about value. How are we enabling science to move faster? How are we reducing risk, improving traceability, or making decisions with better data? That’s the new ask.

AI Is Here, But the Path Isn’t Always Clear

One theme that kept coming up: AI. It’s on everyone’s radar, and coming in hot from the C-suite.

But as many CIOs shared that night, the enthusiasm for AI isn’t always matched with clarity. We’ve all had conversations that go something like:

Executive: “What’s our AI plan?”
IT Leader: “What are we trying to solve?”
Executive: “I’m not sure… but we need it.”

That kind of dialogue isn’t rare, and it’s not a problem if it leads to more meaningful questions. What we discussed was the importance of guiding the conversation. Helping leadership move from abstract interest to actionable need. Are we solving a compliance gap? A productivity bottleneck? A quality issue? If those questions aren’t clear, implementing AI risks becoming a costly guessing game.

The “Bionic Employee”, Less Sci-Fi, More Strategy

We also spent time discussing the concept of the “bionic employee.” Not in the futuristic sense, no cyborgs here, but as a framework for how we empower people through technology. The conversation focused on how automation, smart workflows, and better data access can make teams more efficient, accurate, and empowered.

Imagine removing manual documentation steps that add risk and delay. Or surfacing key data points that help scientists make faster, better-informed decisions. Or giving teams tools that help them stay compliant without getting buried in the process. That’s what this idea is really about: using tech not to replace people, but to make their jobs better and more impactful.

Shared Insight, Shared Momentum

What stood out most from the roundtable wasn’t just what was said, but how aligned many of the attendees were, even with different perspectives and stages of progress.

Some leaders shared how they’re piloting AI in focused areas where the impact can be measured quickly. Others talked about building a data infrastructure that’s audit-ready but agile. A few are rethinking how they hire and train, bringing in roles that can connect technical and business conversations.

Everyone seemed to agree on one thing: the shift is happening. The most important step isn’t having a fully baked strategy; it’s taking the first meaningful step forward.

So What Can You Do With This?

If you’re a CIO, VP, or IT leader in life sciences, you don’t need to overhaul your entire operation overnight. Start by identifying one place where things could be smoother, a lagging workflow, a frustrating report, or a disconnected process. Ask who’s impacted, where the friction is, and what a better version could look like.

Then try something. Design a small fix. Pilot a new approach. Track whether it helps. And if it does, keep going. You don’t need a 12-month transformation roadmap to start delivering impact; you just need to solve one real problem, one step at a time.

Rethinking the Team Behind the Tech

That night, we also explored how the kinds of people we hire and the roles we prioritize, shape how far we can go. It’s not just about headcount or titles. It’s about building teams that understand both the science and the systems.

That might mean hiring people who can speak compliance and architecture in the same sentence. Or investing in team members who understand data flow as well as lab flow. Or encouraging continuous learning so your team evolves with the business.

Transformation doesn’t happen without talent that can make sense of complexity and deliver real, usable solutions across departments.

If You’re Reflecting on Your Next Step, That’s a Good Sign

Maybe you were at the roundtable. Maybe you weren’t. But if any of this sounds familiar, it means you’re already thinking about what needs to shift.

You don’t have to lead every conversation or launch something huge. But you can start showing up differently. Talk about outcomes, not just infrastructure. Think about business value, not just technical correctness. Be the connector, not just the
implementer.

The shift we talked about in Boston isn’t a distant future; it’s already underway. You don’t have to have all the answers. But leaning into the questions? That’s how real leadership starts.

The Takeaway

The SIM Boston roundtable was a reminder of just how much shared learning is out there, and how important it is to come together and talk through it.

The role of the CIO in life sciences is evolving. And with it comes the opportunity to drive smarter, faster, more connected outcomes, not in theory, but in practice.

If you’re ready to lead that shift, start small. Ask better questions. Bring others with you. And build momentum from there.

 

About The Author:
Steve Swan is the founder of The Swan Group, a boutique executive search firm specializing in IT leadership roles within biotech, pharma, and high-growth industries. With over 25 years of experience, Steve has built a reputation for matching high-impact talent with complex, business-critical roles, especially when time is tight and expectations are high. Known for his direct approach and deep understanding of both the technical and human sides of hiring, Steve helps companies move beyond job descriptions to find the right fit, fast.

Are you looking for top IT talent in the pharmaceutical or biotech industry?

Contact us to discuss how we can bring top-tier IT talent to your organization. The Swan Group are executive leaders with extensive IT recruiting expertise in the biotech and pharmaceutical space. Our goal is to ensure that each professional we place and each client we work with achieves a competitive advantage based upon our services.

Are you a professional looking for a new opportunity?

Contact us to discuss your career options or browse our opportunities. As a small boutique firm, we are in the business of building careers, not just filling positions.

ABOUT THE SWAN GROUP

Our goal is to ensure that each professional we place and each client we work with achieves a competitive advantage based upon our services. Our specialty is high-level INFORMATION TECHNOLOGY placement within the Pharmaceutical, Bio-Pharmaceutical, and Consumer Products industries. Thoughts, comments, or would like to discuss further, please contact us.